{{Rsnum
|rsid=2239907
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=17
|Orientation=minus
|Gene=SARM1
|position=28398728
|Gene_s=SARM1,SLC46A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 17.7 | 57.5 | 24.8
| HCB | 5.2 | 42.5 | 52.2
| JPT | 2.7 | 38.9 | 58.4
| YRI | 30.1 | 46.6 | 23.3
| ASW | 22.8 | 56.1 | 21.1
| CHB | 5.2 | 42.5 | 52.2
| CHD | 8.3 | 43.1 | 48.6
| GIH | 31.7 | 50.5 | 17.8
| LWK | 40.7 | 44.4 | 14.8
| MEX | 14.0 | 49.1 | 36.8
| MKK | 27.7 | 54.2 | 18.1
| TSI | 24.8 | 50.5 | 24.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=25124723
|Title=SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms As Predictors Of Methotrexate-Related Toxicity In Portuguese Rheumatoid Arthritis Patients
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}